GAS5 and osteosarcoma: We first evaluated the levels of GAS5, by quantitative real-time PCR (qRT-PCR), in osteosarcoma patients (n = 24) and compared the levels of GAS5 in patients with those in the archived samples from healthy controls (n = 10).